Skip to search formSkip to main contentSkip to account menu

Radotinib

Known as: 4-Methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-(pyrazin-2-yl)pyrimidin-2-ylamino)benzamide 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

IY5511
Receptor Tyrosine Kinase Inhibition

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Radotinib for CML Yields Better Responses Than Imatinib
Among patients with newly diagnosed, chronic-phase chronic myeloid leukemia, a lower-dose regimen of radotinib demonstrated… 
2016
2016
Efficacy and safety evaluation of nilotinib and dasatinib (2G -TKI) on first line treatment in 73 patients with CML-CP outside of clinical trials. Andalusian CML registry (RALMC)
viability, with an IC50 of 20μM for sensitive cells and 25μM for Imatinib resistant cell lines. The cell death was induced by… 
2011
2011
A case of acneiform eruption induced by radotinib (iy5511: hcl) (초)